4.69
price down icon3.30%   -0.16
after-market Dopo l'orario di chiusura: 4.77 0.08 +1.71%
loading
Precedente Chiudi:
$4.85
Aprire:
$5
Volume 24 ore:
18,898
Relative Volume:
0.04
Capitalizzazione di mercato:
$5.30M
Reddito:
-
Utile/perdita netta:
$-36.46M
Rapporto P/E:
-1.9542
EPS:
-2.4
Flusso di cassa netto:
$-30.20M
1 W Prestazione:
-4.48%
1M Prestazione:
+90.65%
6M Prestazione:
+146.19%
1 anno Prestazione:
-27.96%
Intervallo 1D:
Value
$4.38
$5.00
Intervallo di 1 settimana:
Value
$4.255
$5.4837
Portata 52W:
Value
$1.3137
$6.992

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name
Nome
Alaunos Therapeutics Inc
Name
Telefono
(346) 355-4099
Name
Indirizzo
2617 BISSONNET ST, HOUSTON
Name
Dipendente
1
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-12
Name
Ultimi documenti SEC
Name
TCRT's Discussions on Twitter

Confronta TCRT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TCRT
Alaunos Therapeutics Inc
4.69 5.30M 0 -36.46M -30.20M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-10-04 Ripresa Wells Fargo Overweight

Alaunos Therapeutics Inc Borsa (TCRT) Ultime notizie

pulisher
Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - The Manila Times

Jun 18, 2025
pulisher
Jun 18, 2025

PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan

Jun 18, 2025
pulisher
Jun 10, 2025

Alaunos Therapeutics Amends Warrant Agreement with Mast Hill - TipRanks

Jun 10, 2025
pulisher
Jun 06, 2025

Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Update - Defense World

Jun 06, 2025
pulisher
May 16, 2025

Ziopharm: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World

May 16, 2025
pulisher
May 14, 2025

PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics - TipRanks

May 14, 2025
pulisher
May 14, 2025

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan

May 14, 2025
pulisher
Apr 24, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Up 2.5% – Time to Buy? - Defense World

Apr 24, 2025
pulisher
Apr 18, 2025

Alaunos Therapeutics announces board member resignation - Investing.com Australia

Apr 18, 2025
pulisher
Apr 18, 2025

Alaunos Therapeutics announces board member resignation By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 16, 2025

Form 8-KCurrent report - ADVFN

Apr 16, 2025
pulisher
Apr 15, 2025

Alaunos Therapeutics Board Opts for Equity Compensation - TipRanks

Apr 15, 2025
pulisher
Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock - Investing.com

Apr 14, 2025
pulisher
Apr 04, 2025

Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 04, 2025
pulisher
Apr 04, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Down 12.5% in March - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday SessionAllakos (NASDAQ:ALLK), Alumis (NASDAQ:ALMS) - Benzinga

Apr 02, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Mar 31, 2025

Alaunos Therapeutics Inc. (TCRT) reports earnings - Quartz

Mar 31, 2025
pulisher
Mar 27, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Shares Down 6.5% – Here’s What Happened - Defense World

Mar 27, 2025
pulisher
Jan 29, 2025

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - Pharmaceutical Technology

Jan 29, 2025
pulisher
Jan 15, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 4% – Should You Buy? - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Update: Johnson & Johnson acquires Intra-Cellular Therapies - Pharmaceutical Technology

Jan 13, 2025
pulisher
Jan 10, 2025

Light Horse emerges with $62m and Novartis partnership worth up to $1bn - Pharmaceutical Technology

Jan 10, 2025
pulisher
Dec 24, 2024

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Down 0.5% – Time to Sell? - Defense World

Dec 24, 2024
pulisher
Dec 13, 2024

TCRT stock touches 52-week low at $1.92 amid market challenges - Investing.com

Dec 13, 2024
pulisher
Nov 22, 2024

Novartis acquires Kate Therapeutics to advance gene therapies - Pharmaceutical Technology

Nov 22, 2024
pulisher
Nov 14, 2024

Alaunos Therapeutics, Inc. SEC 10-Q Report - TradingView

Nov 14, 2024
pulisher
Oct 11, 2024

Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy - Yahoo Finance

Oct 11, 2024
pulisher
Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024
pulisher
Oct 01, 2024

Genentech buys Regor’s CDK inhibitors in $850m deal - Clinical Trials Arena

Oct 01, 2024
pulisher
Aug 23, 2024

VION Biosciences acquires Echelon Biosciences - Pharmaceutical Technology

Aug 23, 2024
pulisher
Aug 17, 2024

TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com India

Aug 17, 2024
pulisher
Aug 14, 2024

Eli Lilly inaugurates R&D facility in Boston, US - Pharmaceutical Technology

Aug 14, 2024
pulisher
Jul 16, 2024

Alaunos Therapeutics announces 1-for-10 reverse stock split - Investing.com

Jul 16, 2024
pulisher
Mar 27, 2024

Avenzo Therapeutics secures $150m to bolster oncology pipeline - Pharmaceutical Technology

Mar 27, 2024
pulisher
Mar 25, 2024

Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn - Pharmaceutical Technology

Mar 25, 2024
pulisher
Jan 30, 2024

Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks

Jan 30, 2024
pulisher
Jan 25, 2024

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Jan 25, 2024
pulisher
Jan 24, 2024

NAYA buys gene therapy company Florida Biotech for $20m - Clinical Trials Arena

Jan 24, 2024
pulisher
Jan 23, 2024

Genentech signs nanoparticle deal worth up to $644m with GenEdit - Pharmaceutical Technology

Jan 23, 2024
pulisher
Jan 04, 2024

BridGene and Galapagos partner for oncology drugs discovery - Pharmaceutical Technology

Jan 04, 2024
pulisher
Jan 03, 2024

Novartis allies with Voyager to develop gene therapies in $1.3bn deal - Pharmaceutical Technology

Jan 03, 2024
pulisher
Nov 24, 2023

ELABPMGC Holdings Latest Stock News & Market Updates - Stock Titan

Nov 24, 2023

Alaunos Therapeutics Inc Azioni (TCRT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):